These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9431896)

  • 1. Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia.
    Adinolfi LE; Utili R; Zampino R; Ragone E; Mormone G; Ruggiero G
    Eur J Gastroenterol Hepatol; 1997 Nov; 9(11):1067-72. PubMed ID: 9431896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
    Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
    Gragnani L; Fabbrizzi A; Triboli E; Urraro T; Boldrini B; Fognani E; Piluso A; Caini P; Ranieri J; Monti M; Laffi G; Zignego AL
    Dig Liver Dis; 2014 Sep; 46(9):833-7. PubMed ID: 24953206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study.
    Cheng YT; Cheng JS; Lin CH; Chen TH; Lee KC; Chang ML
    Clin Microbiol Infect; 2020 Mar; 26(3):366-372. PubMed ID: 31229596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus.
    Cresta P; Musset L; Cacoub P; Frangeul L; Vitour D; Poynard T; Opolon P; Nguyen DT; Golliot F; Piette JC; Huraux JM; Lunel F
    Gut; 1999 Jul; 45(1):122-8. PubMed ID: 10369715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis.
    Mazzaro C; Panarello G; Carniello S; Faelli A; Mazzi G; Crovatto M; Baracetti S; Nascimben F; Zorat F; Pozzato G; Faccini L; Campanacci L
    Dig Liver Dis; 2000 Nov; 32(8):708-15. PubMed ID: 11142582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study.
    Adinolfi LE; Utili R; Attanasio V; Zampino R; Ragone E; Tripodi MF; Ruggiero G
    Ital J Gastroenterol; 1996 Jan; 28(1):1-9. PubMed ID: 8743066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the presence of serum autoantibodies influence the responsiveness to interferon-alpha 2a treatment in chronic hepatitis C?
    Wada M; Kang KB; Kinugasa A; Shintani S; Sawada K; Nishigami T; Shimoyama T
    Intern Med; 1997 Apr; 36(4):248-54. PubMed ID: 9187562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of interferons in treating children with chronic hepatitis C.
    Matsuoka S; Mori K; Nakano O; Yuasa Y; Taguchi Y; Hayabuchi Y; Kuroda Y
    Eur J Pediatr; 1997 Sep; 156(9):704-8. PubMed ID: 9296534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed cryoglobulinaemia associated with hepatitis C virus infection: a predictor factor for treatment with interferon?
    Pellicano R; Marietti G; Leone N; Arena V; Palmas F; Rizzetto M; Ponzetto A
    J Gastroenterol Hepatol; 1999 Nov; 14(11):1108-11. PubMed ID: 10574139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
    Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
    J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha interferon treatment in chronic hepatitis C.
    Idéo G; Bellobuono A; Mondazzi L; Tempini S; Bellati G; Idéo GM; Silini E
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S167-73. PubMed ID: 8730501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-associated mixed cryoglobulinaemia.
    Dumoulin FL; Spengler U; Sauerbruch T
    Eur J Gastroenterol Hepatol; 1997 Nov; 9(11):1063-5. PubMed ID: 9431895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.
    Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.
    Vandelli C; Renzo F; Braun HB; Tisminetzky S; Albrecht M; De Palma M; Ranzi A; Di Marco G; Stroffolini T; Baralle F; Ventura E; Michel G
    J Med Virol; 1999 May; 58(1):26-34. PubMed ID: 10223542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.